News
-
-
PRESS RELEASE
SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
SPARX Global RCT initiated to advance evidence for drug-coated balloons in complex coronary disease, evaluating DCB-first strategy vs contemporary DES in multinational trial